We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

42 hedge funds and large institutions have $116M invested in Axcella Health Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

16% less capital invested

Capital invested by funds: $138M → $116M (-$22.1M)

18% less funds holding

Funds holding: 5142 (-9)

73% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 11

Holders
42
Holders Change
-9
Holders Change %
-17.65%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
3
Increased
23
Reduced
10
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$58M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$25.3M +$450K +3,648 +2%
HP
3
Harbourvest Partners
Massachusetts
$13M
BlackRock
4
BlackRock
New York
$4.52M +$1.07M +8,651 +28%
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.49M +$113K +919 +2%
AG
6
Artal Group
Luxembourg
$3.29M -$924K -7,500 -21%
State Street
7
State Street
Massachusetts
$924K +$287K +2,331 +41%
Jacobs Levy Equity Management
8
Jacobs Levy Equity Management
New Jersey
$901K +$646K +5,244 +205%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$850K +$131K +1,060 +17%
Northern Trust
10
Northern Trust
Illinois
$800K +$171K +1,390 +25%
ZIM
11
Zacks Investment Management
Illinois
$777K +$829K +6,728 New
Squarepoint
12
Squarepoint
New York
$340K +$236K +1,919 +188%
N
13
Nuveen
North Carolina
$333K +$108K +879 +44%
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$330K +$325K +2,640 +1,200%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$295K +$119K +962 +61%
Marshall Wace
16
Marshall Wace
United Kingdom
$279K -$290K -2,355 -49%
Renaissance Technologies
17
Renaissance Technologies
New York
$261K -$603K -4,896 -68%
First Trust Advisors
18
First Trust Advisors
Illinois
$200K +$214K +1,733 New
Charles Schwab
19
Charles Schwab
California
$193K +$51.3K +416 +33%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$162K -$7.52K -61 -4%
Morgan Stanley
21
Morgan Stanley
New York
$110K +$84.8K +688 +260%
Two Sigma Investments
22
Two Sigma Investments
New York
$82K -$255K -2,069 -74%
Wells Fargo
23
Wells Fargo
California
$76K -$5.42K -44 -6%
JP Morgan Chase
24
JP Morgan Chase
New York
$65K +$31.5K +256 +85%
Russell Investments Group
25
Russell Investments Group
United Kingdom
$65K +$60.1K +488 +610%

AXLA Hedge Fund Activity: Q3 2020 in Review

42 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q3 2020, worth a combined $116M — down 16% from $138M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of AXLA and 3 opened new positions — a net loss of 8 holders — while 10 trimmed existing stakes and 23 added.

The largest buyer was BlackRock, adding an estimated $1.07M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $1.24M sold.

  • 42 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q3 2020, down from 51 in Q2 2020.
  • Funds reported $116M of Axcella Health Inc. Common Stock stock for Q3 2020, down 16% quarter-over-quarter.
  • 3 funds opened new Axcella Health Inc. Common Stock positions in Q3 2020 and 11 closed out, a net change of -8 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q3 2020 was BlackRock, an estimated $1.07M added.
  • The largest Axcella Health Inc. Common Stock seller in Q3 2020 was Monashee Investment Management, an estimated $1.24M sold.

Based on aggregated 13F filings for Q3 2020.